159 related articles for article (PubMed ID: 38804179)
61. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
[TBL] [Abstract][Full Text] [Related]
62. COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest.
Chen AT; Altschuler K; Zhan SH; Chan YA; Deverman BE
Elife; 2021 Feb; 10():. PubMed ID: 33620031
[TBL] [Abstract][Full Text] [Related]
63. Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.
Hirotsu Y; Omata M
PLoS Pathog; 2021 Jun; 17(6):e1009619. PubMed ID: 34097716
[TBL] [Abstract][Full Text] [Related]
64. The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical Impact in Mexico City.
Cedro-Tanda A; Gómez-Romero L; Alcaraz N; de Anda-Jauregui G; Peñaloza F; Moreno B; Escobar-Arrazola MA; Ramirez-Vega OA; Munguia-Garza P; Garcia-Cardenas F; Cisneros-Villanueva M; Moreno-Camacho JL; Rodriguez-Gallegos J; Luna-Ruiz Esparza MA; Fernández Rojas MA; Mendoza-Vargas A; Reyes-Grajeda JP; Campos-Romero A; Angulo O; Ruiz R; Sheinbaum-Pardo C; Sifuentes-Osornio J; Kershenobich D; Hidalgo-Miranda A; Herrera LA
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834987
[TBL] [Abstract][Full Text] [Related]
65. Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K.
Di Giacomo S; Mercatelli D; Rakhimov A; Giorgi FM
J Med Virol; 2021 Sep; 93(9):5638-5643. PubMed ID: 33951211
[TBL] [Abstract][Full Text] [Related]
66. Genomic epidemiology of SARS-CoV-2 from Uttar Pradesh, India.
Misra G; Manzoor A; Chopra M; Upadhyay A; Katiyar A; Bhushan B; Anvikar A
Sci Rep; 2023 Sep; 13(1):14847. PubMed ID: 37684328
[TBL] [Abstract][Full Text] [Related]
67. Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
Moyo-Gwete T; Madzivhandila M; Mkhize NN; Kgagudi P; Ayres F; Lambson BE; Manamela NP; Richardson SI; Makhado Z; van der Mescht MA; de Beer Z; de Villiers TR; Burgers WA; Ntusi NAB; Rossouw T; Ueckermann V; Boswell MT; Moore PL
J Virol; 2022 Aug; 96(15):e0055822. PubMed ID: 35867572
[TBL] [Abstract][Full Text] [Related]
68. Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B.1.524 and AU.2 in Malaysia.
Zainulabid UA; Mat Yassim AS; Hussain M; Aslam A; Soffian SN; Mohd Ibrahim MS; Kamarudin N; Kamarulzaman MN; Hin HS; Ahmad HF
PLoS One; 2022; 17(2):e0263678. PubMed ID: 35213571
[TBL] [Abstract][Full Text] [Related]
69. Spatio-temporal dynamics of intra-host variability in SARS-CoV-2 genomes.
Pathak AK; Mishra GP; Uppili B; Walia S; Fatihi S; Abbas T; Banu S; Ghosh A; Kanampalliwar A; Jha A; Fatma S; Aggarwal S; Dhar MS; Marwal R; Radhakrishnan VS; Ponnusamy K; Kabra S; Rakshit P; Bhoyar RC; Jain A; Divakar MK; Imran M; Faruq M; Sowpati DT; Thukral L; Raghav SK; Mukerji M
Nucleic Acids Res; 2022 Feb; 50(3):1551-1561. PubMed ID: 35048970
[TBL] [Abstract][Full Text] [Related]
70. Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern.
Abdulnoor M; Eshaghi A; Perusini SJ; Broukhanski G; Corbeil A; Cronin K; Fittipaldi N; Forbes JD; Guthrie JL; Kus JV; Li Y; Majury A; Mallo GV; Mazzulli T; Melano RG; Olsha R; Sullivan A; Tran V; Patel SN; Allen VG; Gubbay JB
Microbiol Spectr; 2022 Feb; 10(1):e0068121. PubMed ID: 35170989
[TBL] [Abstract][Full Text] [Related]
71. Intra-Host SARS-CoV-2 Evolution in the Gut of Mucosally-Infected
Rowe LA; Beddingfield BJ; Goff K; Killeen SZ; Chirichella NR; Melton A; Roy CJ; Maness NJ
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062281
[TBL] [Abstract][Full Text] [Related]
72. Genomic Evolution and Variation of SARS-CoV-2 in the Early Phase of COVID-19 Pandemic in Guangdong Province, China.
Li BS; Li ZC; Hu Y; Liang LJ; Zou LR; Guo QF; Zheng ZH; Yu JX; Song T; Wu J
Curr Med Sci; 2021 Apr; 41(2):228-235. PubMed ID: 33877539
[TBL] [Abstract][Full Text] [Related]
73. Circulation and Evolution of SARS-CoV-2 in India: Let the Data Speak.
Limaye S; Kasibhatla SM; Ramtirthkar M; Kinikar M; Kale MM; Kulkarni-Kale U
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835044
[TBL] [Abstract][Full Text] [Related]
74. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
Cao Y; Yisimayi A; Jian F; Song W; Xiao T; Wang L; Du S; Wang J; Li Q; Chen X; Yu Y; Wang P; Zhang Z; Liu P; An R; Hao X; Wang Y; Wang J; Feng R; Sun H; Zhao L; Zhang W; Zhao D; Zheng J; Yu L; Li C; Zhang N; Wang R; Niu X; Yang S; Song X; Chai Y; Hu Y; Shi Y; Zheng L; Li Z; Gu Q; Shao F; Huang W; Jin R; Shen Z; Wang Y; Wang X; Xiao J; Xie XS
Nature; 2022 Aug; 608(7923):593-602. PubMed ID: 35714668
[TBL] [Abstract][Full Text] [Related]
75. Molecular Evolution and Epidemiological Characteristics of SARS COV-2 in (Northwestern) Poland.
Serwin K; Ossowski A; Szargut M; Cytacka S; Urbańska A; Majchrzak A; Niedźwiedź A; Czerska E; Pawińska-Matecka A; Gołąb J; Parczewski M
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372500
[TBL] [Abstract][Full Text] [Related]
76. Identification of Various Recombinants in a Patient Coinfected With the Different SARS-CoV-2 Variants.
Sayama Y; Sakagami A; Okamoto M; Sakamoto M; Koizumi H; Kimura Y; Dapat C; Saito M; Suzuki Y; Sasaki M; Sugawara N; Oshitani H
Influenza Other Respir Viruses; 2024 Jun; 18(6):e13340. PubMed ID: 38890805
[TBL] [Abstract][Full Text] [Related]
77. Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2.
Pastorio C; Zech F; Noettger S; Jung C; Jacob T; Sanderson T; Sparrer KMJ; Kirchhoff F
Cell Host Microbe; 2022 Sep; 30(9):1255-1268.e5. PubMed ID: 35931073
[TBL] [Abstract][Full Text] [Related]
78. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
Volz E; Hill V; McCrone JT; Price A; Jorgensen D; O'Toole Á; Southgate J; Johnson R; Jackson B; Nascimento FF; Rey SM; Nicholls SM; Colquhoun RM; da Silva Filipe A; Shepherd J; Pascall DJ; Shah R; Jesudason N; Li K; Jarrett R; Pacchiarini N; Bull M; Geidelberg L; Siveroni I; ; Goodfellow I; Loman NJ; Pybus OG; Robertson DL; Thomson EC; Rambaut A; Connor TR
Cell; 2021 Jan; 184(1):64-75.e11. PubMed ID: 33275900
[TBL] [Abstract][Full Text] [Related]
79. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.
Molina-Mora JA; Cordero-Laurent E; Godínez A; Calderón-Osorno M; Brenes H; Soto-Garita C; Pérez-Corrales C; ; Drexler JF; Moreira-Soto A; Corrales-Aguilar E; Duarte-Martínez F
Infect Genet Evol; 2021 Aug; 92():104872. PubMed ID: 33905892
[TBL] [Abstract][Full Text] [Related]
80. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.
Zaheer M; Ali N; Javed H; Munir R; Jamil N
J Infect Public Health; 2023 Oct; 16(10):1544-1555. PubMed ID: 37566991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
